Autopsy report · NCT03675022
Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
Cause of deathSlow enrollment, also staffing, sites or logistics
“Inability to recruit during COVID”
Life of this trial
- Ran for about 3 years 11 months before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Early Phase 1
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Sleep Apnea; Rhinosinusitis Chronic
- Interventions
- Dupilumab
- Participants
- 9
- Sites
- 1
- Countries
- United States
Trials that died the same way
- (mo)BETTA Trial in Transwomen for Optimization of ART
“Lack of ability to recruit due to COVID-19 pandemic” - Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow
“Covid 19 and difficulty with recruitment” - Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia
“Hard to recruit due to COVID-19 issue.” - Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants
“Due to Covid constraints on recruitment” - Impact of the Information Follow-up Given to Patients on Their Disease Understanding and Therapeutic Adherence in Patients Under Direct Oral Anticoagulants and With Atrial Fibrillation in a Cardiology Department
“Recruitment incomplete due to COVID”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.